Related Experiment Videos
Pseudomembranous tracheobronchitis caused by Aspergillus in immunocompromised patients
Shang-Miao Chang1, Hsu-Tah Kuo, Fung-J Lin
1Chest Division, Department of Medicine, Mackay Memorial Hospital, No. 92, Section 2, Chung-San N Road, Taipei, Taiwan.
Scandinavian Journal of Infectious Diseases
|November 26, 2005
Summary
Aspergillus pseudomembranous tracheobronchitis is a rare fungal infection. Early diagnosis and treatment are crucial for survival in immunocompromised patients, especially those with diabetes.
Area of Science:
- Pulmonology
- Infectious Diseases
- Mycology
Background:
- Aspergillus pseudomembranous tracheobronchitis is a severe airway infection.
- Diabetes mellitus is a common comorbidity in patients with invasive fungal infections.
Observation:
- Two cases of Aspergillus pseudomembranous tracheobronchitis in diabetic patients are presented.
- One patient experienced fatal obstructive respiratory failure despite treatment.
- The second patient recovered with appropriate medical intervention.
Findings:
- Aspergillus tracheobronchitis presents with cough, chest pain, fever, dyspnea, and upper airway obstruction.
- Diagnosis requires early bronchoscopy and histologic examination.
- Prompt and targeted antifungal therapy is critical.
Implications:
- This condition should be considered in immunocompromised individuals with respiratory symptoms.
- Timely diagnosis and treatment can be life-saving.
- Further research into Aspergillus tracheobronchitis in diabetic populations is warranted.